GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » ROE % Adjusted to Book Value

K Pharma (TSE:4896) ROE % Adjusted to Book Value : -12.55% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is K Pharma ROE % Adjusted to Book Value?

K Pharma's ROE % for the quarter that ended in Mar. 2024 was -31.25%. K Pharma's PB Ratio for the quarter that ended in Mar. 2024 was 2.49. K Pharma's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -12.55%.


K Pharma ROE % Adjusted to Book Value Historical Data

The historical data trend for K Pharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma ROE % Adjusted to Book Value Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
- - 4.36

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial - - - -8.47 -12.55

Competitive Comparison of K Pharma's ROE % Adjusted to Book Value

For the Biotechnology subindustry, K Pharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


K Pharma's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, K Pharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where K Pharma's ROE % Adjusted to Book Value falls into.



K Pharma ROE % Adjusted to Book Value Calculation

K Pharma's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=11.72% / 2.69
=4.36%

K Pharma's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-31.25% / 2.49
=-12.55%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


K Pharma ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of K Pharma's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


K Pharma (TSE:4896) Business Description

Industry
Traded in Other Exchanges
N/A
Address
7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma (TSE:4896) Headlines

No Headlines